Related Experiment Video
Updated: Aug 25, 2025
Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
Published on: September 27, 2024
Pancreatic Cancer Cell-Derived Exosomes Promote Lymphangiogenesis by Downregulating ABHD11-AS1 Expression
Xulin Zhou1, Fengyun Zhong2, Yongmin Yan3
1Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China.
Abstract:
Research on pancreatic cancer microbiomes has attracted attention in recent years. The current view is that enriched microbial communities in pancreatic cancer tissues may affect pancreatic cancer metastasis, including lymph node (LN) metastasis. Similar to carriers of genetic information between cells, such as DNA, mRNA, protein, and non-coding RNA, exosomes are of great importance in early LN metastasis in tumors, including pancreatic cancer. Our previous study showed that the long non-coding RNA ABHD11-AS1 was highly expressed in tissues of patients with pancreatic cancer, and was correlated with patient survival time. However, the role of ABHD11-AS1 in pancreatic cancer LN metastasis has rarely been studied. Hence, in this paper we confirmed that exosomes derived from pancreatic cancer cells could promote lymphangiogenesis in vitro and in vivo, and that the mechanism was related to the downregulation of ABHD11-AS1 expression in lymphatic endothelial cells, and to the enhancement of their ability to proliferate, migrate, and form tubes. These findings preliminarily show a new mechanism by which pancreatic cancer cells regulate peripheral lymphangiogenesis, providing a new therapeutic strategy for inhibiting LN metastasis in pancreatic cancer.
Insights
Pancreatic cancer exosomes promote lymph node metastasis by downregulating ABHD11-AS1 in lymphatic cells. This research reveals a new mechanism for pancreatic cancer spread and suggests novel therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis Research
Background:
- Pancreatic cancer research is increasingly focused on the microbiome's role in metastasis.
- Exosomes are crucial in early lymph node (LN) metastasis for tumors like pancreatic cancer.
- Long non-coding RNA ABHD11-AS1 is highly expressed in pancreatic cancer and linked to survival.
Purpose of the Study:
- To investigate the role of ABHD11-AS1 in pancreatic cancer lymph node metastasis.
- To elucidate the mechanism by which pancreatic cancer exosomes influence lymphangiogenesis.
Main Methods:
- In vitro and in vivo experiments using exosomes derived from pancreatic cancer cells.
- Analysis of ABHD11-AS1 expression in lymphatic endothelial cells.
- Assessment of lymphatic endothelial cell proliferation, migration, and tube formation.
Main Results:
- Pancreatic cancer exosomes promote lymphangiogenesis both in vitro and in vivo.
- Exosomes downregulate ABHD11-AS1 expression in lymphatic endothelial cells.
- This downregulation enhances lymphatic endothelial cell proliferation, migration, and tube formation.
Conclusions:
- Pancreatic cancer cells utilize exosomes to promote peripheral lymphangiogenesis.
- A novel mechanism involving ABHD11-AS1 downregulation by exosomes in lymphangiogenesis is identified.
- These findings offer a potential new therapeutic strategy for inhibiting pancreatic cancer LN metastasis.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
06:21Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019